Primary Prevention

"Primary Prevention" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION.

Descriptor ID	D011322
MeSH Number(s)	N02.421.726.758 N06.850.780.680
Concept/Terms	Primary Prevention Primary Prevention Disease Prevention, Primary Disease Preventions, Primary Primary Disease Prevention Primary Disease Preventions Prevention, Primary Primordial Prevention Primordial Prevention Preventions, Primordial Primordial Preventions Prevention, Primordial

Below are MeSH descriptors whose meaning is more general than "Primary Prevention".

Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Primary Prevention [N02.421.726.758]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Primary Prevention [N06.850.780.680]

Below are MeSH descriptors whose meaning is more specific than "Primary Prevention".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Primary Prevention" by people in this website by year, and whether "Primary Prevention" was a major or minor topic of these publications.

Bar chart showing 96 publications over 28 distinct years, with a maximum of 10 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	0	1	1
1998	0	2	2
1999	1	1	2
2001	1	1	2
2002	1	2	3
2003	2	4	6
2004	0	4	4
2005	1	4	5
2006	0	3	3
2007	1	0	1
2008	3	3	6
2009	1	2	3
2010	2	4	6
2011	1	4	5
2012	2	0	2
2013	0	1	1
2014	6	4	10
2015	2	1	3
2016	3	0	3
2017	2	1	3
2018	6	1	7
2019	2	0	2
2020	1	4	5
2021	1	0	1
2022	0	2	2
2023	0	2	2
2024	3	2	5

Below are the most recent publications written about "Primary Prevention" by people in Profiles.

Bao A, Karalis DG. Statin Therapy for Primary and Secondary Prevention in Older Adults. Curr Atheroscler Rep. 2024 Nov 25; 27(1):11.

View in: PubMed
Hamaya R, Wang M, Hertzmark E, Cook NR, Manson JE, Sun Q, Stampfer MJ, Mukamal KJ, Curhan G, Rimm EB. Modifiable lifestyle factors in the primordial prevention of hypertension in three US cohorts. Eur J Intern Med. 2025 Feb; 132:55-66.

View in: PubMed
Kobo O, Michos ED, Roguin A, Bagur R, Gulati M, Mamas MA. Recommended and observed statin use among US adults with and without cancer. Eur J Prev Cardiol. 2024 Aug 09; 31(10):1251-1257.

View in: PubMed
Srivastava S, Nahass M, Hiltner E, Sethi A, Kassotis J. Gender Disparity of Automatic Implantable Cardioverter-Defibrillator Placement for Primary Prevention: National Inpatient Sample Analysis. Cardiology. 2025; 150(2):184-190.

View in: PubMed
Gidding SS. Addressing Knowledge Gaps in the Primary Prevention of Atherosclerotic Heart Disease. J Am Heart Assoc. 2024 Mar 19; 13(6):e033991.

View in: PubMed
Segar MW, Keshvani N, Singh S, Patel L, Parsa S, Betts T, Reeves GR, Mentz RJ, Forman DE, Razavi M, Saeed M, Kitzman DW, Pandey A. Frailty Status Modifies the Efficacy of?ICD?Therapy for Primary Prevention Among Patients With HF. JACC Heart Fail. 2024 Apr; 12(4):757-767.

View in: PubMed
Pant A, Gribbin S, McIntyre D, Trivedi R, Marschner S, Laranjo L, Mamas MA, Flood V, Chow CK, Zaman S. Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis. Heart. 2023 07 27; 109(16):1208-1215.

View in: PubMed
Wright AK, Carr MJ, Kontopantelis E, Leelarathna L, Thabit H, Emsley R, Buchan I, Mamas MA, van Staa TP, Sattar N, Ashcroft DM, Rutter MK. Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. 2022 04 01; 45(4):909-918.

View in: PubMed
Tai WA. Stroke: Primary Prevention. FP Essent. 2022 Jan; 512:11-17.

View in: PubMed
Krebs J, Mansi T, Delingette H, Lou B, Lima JAC, Tao S, Ciuffo LA, Norgard S, Butcher B, Lee WH, Chamera E, Dickfeld TM, Stillabower M, Marine JE, Weiss RG, Tomaselli GF, Halperin H, Wu KC, Ashikaga H. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY). Sci Rep. 2021 11 22; 11(1):22683.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement